• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPECTOR 可根据比较 NGS 数据准确估计基因组编辑的易位和脱靶活性。

CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data.

机构信息

Arazi School of Computer Science, Interdisciplinary Center, Herzliya, Israel.

The Institute for Advanced Materials and Nanotechnology, The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

出版信息

Nat Commun. 2021 May 24;12(1):3042. doi: 10.1038/s41467-021-22417-4.

DOI:10.1038/s41467-021-22417-4
PMID:34031394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8144550/
Abstract

Controlling off-target editing activity is one of the central challenges in making CRISPR technology accurate and applicable in medical practice. Current algorithms for analyzing off-target activity do not provide statistical quantification, are not sufficiently sensitive in separating signal from noise in experiments with low editing rates, and do not address the detection of translocations. Here we present CRISPECTOR, a software tool that supports the detection and quantification of on- and off-target genome-editing activity from NGS data using paired treatment/control CRISPR experiments. In particular, CRISPECTOR facilitates the statistical analysis of NGS data from multiplex-PCR comparative experiments to detect and quantify adverse translocation events. We validate the observed results and show independent evidence of the occurrence of translocations in human cell lines, after genome editing. Our methodology is based on a statistical model comparison approach leading to better false-negative rates in sites with weak yet significant off-target activity.

摘要

控制脱靶编辑活性是使 CRISPR 技术在医学实践中准确和适用的核心挑战之一。目前用于分析脱靶活性的算法没有提供统计量化,在编辑率低的实验中不足以从信号中分离噪声,并且不能解决易位的检测问题。在这里,我们介绍了 CRISPECTOR,这是一种软件工具,可使用配对的处理/对照 CRISPR 实验从 NGS 数据中支持检测和定量的靶和脱靶基因组编辑活性。特别是,CRISPECTOR 便于对多重 PCR 比较实验的 NGS 数据进行统计分析,以检测和定量不良易位事件。我们验证了观察到的结果,并在基因组编辑后显示了人细胞系中转位发生的独立证据。我们的方法基于统计模型比较方法,导致在弱但具有显著脱靶活性的位点具有更好的假阴性率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/8144550/e2828f4e388b/41467_2021_22417_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/8144550/dc34c8ddb3ee/41467_2021_22417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/8144550/b4bf40414333/41467_2021_22417_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/8144550/e2828f4e388b/41467_2021_22417_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/8144550/dc34c8ddb3ee/41467_2021_22417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/8144550/b4bf40414333/41467_2021_22417_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/8144550/e2828f4e388b/41467_2021_22417_Fig3_HTML.jpg

相似文献

1
CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data.CRISPECTOR 可根据比较 NGS 数据准确估计基因组编辑的易位和脱靶活性。
Nat Commun. 2021 May 24;12(1):3042. doi: 10.1038/s41467-021-22417-4.
2
Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.无扩增长读测序揭示了意想不到的 CRISPR-Cas9 脱靶活性。
Genome Biol. 2020 Dec 1;21(1):290. doi: 10.1186/s13059-020-02206-w.
3
Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0.利用 CRISPECTOR2.0 定量分析等位基因特异性 CRISPR 编辑活性。
Nucleic Acids Res. 2024 Sep 9;52(16):e78. doi: 10.1093/nar/gkae651.
4
Web-Based CRISPR Toolkits: Cas-OFFinder, Cas-Designer, and Cas-Analyzer.基于网络的 CRISPR 工具包:Cas-OFFinder、Cas-Designer 和 Cas-Analyzer。
Methods Mol Biol. 2021;2162:23-33. doi: 10.1007/978-1-0716-0687-2_2.
5
OffScan: a universal and fast CRISPR off-target sites detection tool.OffScan:一种通用且快速的 CRISPR 脱靶位点检测工具。
BMC Genomics. 2020 Mar 5;21(Suppl 1):872. doi: 10.1186/s12864-019-6241-9.
6
Tools for experimental and computational analyses of off-target editing by programmable nucleases.可编程核酸酶脱靶编辑的实验和计算分析工具。
Nat Protoc. 2021 Jan;16(1):10-26. doi: 10.1038/s41596-020-00431-y. Epub 2020 Dec 7.
7
WheatCRISPR: a web-based guide RNA design tool for CRISPR/Cas9-mediated genome editing in wheat.小麦 CRISPR:一个基于网络的 guide RNA 设计工具,用于小麦中 CRISPR/Cas9 介导的基因组编辑。
BMC Plant Biol. 2019 Nov 6;19(1):474. doi: 10.1186/s12870-019-2097-z.
8
VARSCOT: variant-aware detection and scoring enables sensitive and personalized off-target detection for CRISPR-Cas9.VARSCOT:变体感知检测和评分可实现 CRISPR-Cas9 的敏感和个性化脱靶检测。
BMC Biotechnol. 2019 Jun 27;19(1):40. doi: 10.1186/s12896-019-0535-5.
9
FokI-dCas9 mediates high-fidelity genome editing in pigs.FokI-dCas9 介导猪的高保真基因组编辑。
Xenotransplantation. 2020 Jan;27(1):e12551. doi: 10.1111/xen.12551. Epub 2019 Aug 12.
10
Computational Tools and Resources Supporting CRISPR-Cas Experiments.支持 CRISPR-Cas 实验的计算工具和资源。
Cells. 2020 May 22;9(5):1288. doi: 10.3390/cells9051288.

引用本文的文献

1
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges.用于人类治疗的CRISPR-Cas基因组编辑中的脱靶效应:进展与挑战。
Mol Ther Nucleic Acids. 2025 Jul 17;36(3):102636. doi: 10.1016/j.omtn.2025.102636. eCollection 2025 Sep 9.
2
Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of Detected by Long-Read Sequencing.通过长读长测序检测基因家族中CRISPR/Cas9编辑的交叉活性分析
Curr Issues Mol Biol. 2025 Jul 2;47(7):507. doi: 10.3390/cimb47070507.
3
Single-guide RNA Cas9 and enhanced-deletion Cas9 rescue a recurrent -related splicing defect.

本文引用的文献

1
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System.利用临床相关系统提高CRISPR在造血干细胞中的效率并检测其特异性
Mol Ther Methods Clin Dev. 2020 May 4;17:1097-1107. doi: 10.1016/j.omtm.2020.04.027. eCollection 2020 Jun 12.
2
The emerging and uncultivated potential of CRISPR technology in plant science.CRISPR 技术在植物科学中的新兴未开发潜力。
Nat Plants. 2019 Aug;5(8):778-794. doi: 10.1038/s41477-019-0461-5. Epub 2019 Jul 15.
3
Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq.
单向导RNA Cas9和增强型缺失Cas9挽救了一种复发性相关剪接缺陷。
Mol Ther Nucleic Acids. 2025 Mar 21;36(2):102523. doi: 10.1016/j.omtn.2025.102523. eCollection 2025 Jun 10.
4
Precise measurement of CRISPR genome editing outcomes through single-cell DNA sequencing.通过单细胞DNA测序精确测量CRISPR基因组编辑结果。
Mol Ther Methods Clin Dev. 2025 Mar 14;33(2):101449. doi: 10.1016/j.omtm.2025.101449. eCollection 2025 Jun 12.
5
CRISPRoffT: comprehensive database of CRISPR/Cas off-targets.CRISPRoffT:CRISPR/Cas脱靶效应的综合数据库。
Nucleic Acids Res. 2025 Jan 6;53(D1):D914-D924. doi: 10.1093/nar/gkae1025.
6
Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0.利用 CRISPECTOR2.0 定量分析等位基因特异性 CRISPR 编辑活性。
Nucleic Acids Res. 2024 Sep 9;52(16):e78. doi: 10.1093/nar/gkae651.
7
T4 DNA polymerase prevents deleterious on-target DNA damage and enhances precise CRISPR editing.T4 DNA 聚合酶可预防有害的靶 DNA 损伤,并提高精确的 CRISPR 编辑效率。
EMBO J. 2024 Sep;43(17):3733-3751. doi: 10.1038/s44318-024-00158-6. Epub 2024 Jul 22.
8
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.CRISPR-Cas9n 介导的 ELANE 启动子编辑用于严重先天性中性粒细胞减少症的基因治疗。
Mol Ther. 2024 Jun 5;32(6):1628-1642. doi: 10.1016/j.ymthe.2024.03.037. Epub 2024 Mar 30.
9
Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9.利用 CRISPR/Cas9 技术生成由于抗原加工/呈递或 IFNγ 信号缺陷而对 αPD-1/-L1 治疗产生耐药性的小鼠肿瘤模型。
PLoS One. 2024 Mar 1;19(3):e0287733. doi: 10.1371/journal.pone.0287733. eCollection 2024.
10
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1.高效、安全的 Cas9 内切酶-尼克酰胺酶对 1 型原发性高草酸尿症的治疗作用。
EMBO Mol Med. 2024 Jan;16(1):112-131. doi: 10.1038/s44321-023-00008-8. Epub 2024 Jan 5.
利用 DISCOVER-Seq 在体内无偏检测 CRISPR 脱靶效应。
Science. 2019 Apr 19;364(6437):286-289. doi: 10.1126/science.aav9023. Epub 2019 Apr 18.
4
Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.评估和增强基因编辑核酸酶和脱氨酶的靶特异性。
Annu Rev Biochem. 2019 Jun 20;88:191-220. doi: 10.1146/annurev-biochem-013118-111730. Epub 2019 Mar 18.
5
CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing.CRIS.py:一个用于基于 CRISPR 的基因组编辑的通用、高通量分析程序。
Sci Rep. 2019 Mar 12;9(1):4194. doi: 10.1038/s41598-019-40896-w.
6
A New Class of Medicines through DNA Editing.通过DNA编辑产生的一类新型药物。
N Engl J Med. 2019 Mar 7;380(10):947-959. doi: 10.1056/NEJMra1800729.
7
Accurate analysis of genuine CRISPR editing events with ampliCan.利用 ampliCan 对真实的 CRISPR 编辑事件进行精确分析。
Genome Res. 2019 May;29(5):843-847. doi: 10.1101/gr.244293.118. Epub 2019 Mar 8.
8
CRISPResso2 provides accurate and rapid genome editing sequence analysis.CRISPResso2可提供准确且快速的基因组编辑序列分析。
Nat Biotechnol. 2019 Mar;37(3):224-226. doi: 10.1038/s41587-019-0032-3.
9
fastp: an ultra-fast all-in-one FASTQ preprocessor.fastp:一个超快速的一体化 FASTQ 预处理程序。
Bioinformatics. 2018 Sep 1;34(17):i884-i890. doi: 10.1093/bioinformatics/bty560.
10
Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence.功能 CRISPR 筛选鉴定出与 AP1 相关的增强子,该增强子调节 FOXF1 以调节癌基因诱导的衰老。
Genome Biol. 2018 Aug 17;19(1):118. doi: 10.1186/s13059-018-1494-1.